Parkinson's disease is a chronic neurodegenerative disorder of unknown etiology. There are sparse data on gender differences in this disorder, but it is clear that there are gender discrepancies in incidence, symptoms, medication effects and treatments. There also appear to be lifecycle fluctuations in the disease course of female Parkinson's disease patients. The effect of estrogen in this disorder is multifold and its role in the development and treatment of PD will be discussed.
No takes yet. Share an insight, caveat, or question.
Shulman et al. (2006) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: